Effect of Implementation of an Early Treatment of Sepsis Protocol on Surgical Outcomes.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 28 4 2022
medline: 21 9 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

Sepsis outcomes remain high regarding mortality and morbidity, despite efforts to reduce them. We retrospectively evaluated a protocol in the first 6 months of implementation to measure outcomes. Retrospective data collection and analysis was performed of 200 consecutive patients seen in the ED during the first 4 months of 2020 after implementation of the sepsis protocol (group 1) and compared to another 200 consecutive patients during the same time frame in 2019 before the sepsis protocol (group 2). The collected parameters included age, gender, race, length of stay comorbid conditions, mortality, and therapy received. Statistical significance was determined at a p-value ≤.05. Mean age and gender of the groups were similar, 64 vs 66 years for group 1 and 2, respectively. Each group was 45% male. Mean length of stay were 8.9 and 8.6 days in group 1 and 2, respectively. Group 1 had a mortality rate of 13% vs 18% in group 2 (p = .21). Comorbid conditions including cardiovascular disease, diabetes, renal failure, and COPD were analyzed regarding mortality that influenced outcomes using Cox regression analysis. COPD and diabetic patient mortality were significantly lower in the protocol group. Surgical patients had a survival rate of 92.4%. Therefore, the current protocol for sepsis management did improve mortality. Further studies with a larger number of patients are in progress.

Identifiants

pubmed: 35476539
doi: 10.1177/00031348221091971
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2227-2229

Auteurs

Tarik Wasfie (T)

Department of Surgery/Trauma, 3577Ascension Genesys Hospital, Grand Blanc, MI, USA.

Anna Buzadzhi (A)

Department of Surgery/Trauma, 3577Ascension Genesys Hospital, Grand Blanc, MI, USA.

Mursal Naisan (M)

Medical University of the Americas, Devens, MA, USA.

Chase Cataline (C)

College of Osteopathic Medicine, 3078Michigan State University, East Lansing, MI, USA.

Ada Ahmady (A)

College of Osteopathic Medicine, 3078Michigan State University, East Lansing, MI, USA.

Victor Wong (V)

College of Osteopathic Medicine, 3078Michigan State University, East Lansing, MI, USA.

Jared Hicken (J)

14412AT. Still University, School of Osteopathic Medicine, Kirksville, MO, USA.

Mikayla Depuydt (M)

College of Osteopathic Medicine, 3078Michigan State University, East Lansing, MI, USA.

Jennifer Hella (J)

Department of Academic Research, 3577Ascension Genesys Hospital, Grand Blanc, MI, USA.

Barbara Senger (B)

14412AT. Still University, School of Osteopathic Medicine, Kirksville, MO, USA.

Kimberly Barber (K)

Department of Academic Research, 3577Ascension Genesys Hospital, Grand Blanc, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH